Login / Signup

Prognostic Factors in Advanced Adrenocortical Carcinoma: Summary of a National Referral Center's 20 years of Experience.

Johnathan ArnonSimona Grozinsky-GlasbergKira OleinikovDavid J GrossAsher SalmonAmichay MeirovitzOfra Maimon
Published in: Journal of the Endocrine Society (2022)
Patients with advanced ACC achieving R0 status have a better prognosis and might benefit from mitotane monotherapy.
Keyphrases
  • prognostic factors
  • quality improvement
  • primary care
  • combination therapy
  • open label